Spero Therapeutics
SPRO
#10353
Rank
C$61.99 M
Marketcap
C$1.06
Share price
-10.20%
Change (1 day)
-68.27%
Change (1 year)

EPS for Spero Therapeutics (SPRO)

EPS in 2026 (TTM): C$0.18

According to Spero Therapeutics's latest financial reports the company's current EPS (TTM) is C$0.20. In 2025 the company made an earnings per share (EPS) of C$0.22 an increase over its 2024 EPS that were of C-$1.82.

EPS history for Spero Therapeutics from 2017 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$0.18-17.3%
2025C$0.22-111.81%
2024C-$1.82
2022C-$2.38
2020C-$5.189.39%
2019C-$4.7325.48%
2018C-$3.77-51.35%
2017C-$7.75

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
IBM
IBM
C$17.06 8,400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Thomson Reuters
TRI
C$5.16 2,469.83%๐Ÿ‡จ๐Ÿ‡ฆ Canada
Franklin Covey
FC
C$0.66 228.57%๐Ÿ‡บ๐Ÿ‡ธ USA